BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 25393546)

  • 1. Quantitative analysis of tissue distribution of the B16BL6-derived exosomes using a streptavidin-lactadherin fusion protein and iodine-125-labeled biotin derivative after intravenous injection in mice.
    Morishita M; Takahashi Y; Nishikawa M; Sano K; Kato K; Yamashita T; Imai T; Saji H; Takakura Y
    J Pharm Sci; 2015 Feb; 104(2):705-13. PubMed ID: 25393546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage-dependent clearance of systemically administered B16BL6-derived exosomes from the blood circulation in mice.
    Imai T; Takahashi Y; Nishikawa M; Kato K; Morishita M; Yamashita T; Matsumoto A; Charoenviriyakul C; Takakura Y
    J Extracell Vesicles; 2015; 4():26238. PubMed ID: 25669322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection.
    Takahashi Y; Nishikawa M; Shinotsuka H; Matsui Y; Ohara S; Imai T; Takakura Y
    J Biotechnol; 2013 May; 165(2):77-84. PubMed ID: 23562828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Phosphatidylserine-Derived Negative Surface Charges in the Recognition and Uptake of Intravenously Injected B16BL6-Derived Exosomes by Macrophages.
    Matsumoto A; Takahashi Y; Nishikawa M; Sano K; Morishita M; Charoenviriyakul C; Saji H; Takakura Y
    J Pharm Sci; 2017 Jan; 106(1):168-175. PubMed ID: 27649887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosome-based tumor antigens-adjuvant co-delivery utilizing genetically engineered tumor cell-derived exosomes with immunostimulatory CpG DNA.
    Morishita M; Takahashi Y; Matsumoto A; Nishikawa M; Takakura Y
    Biomaterials; 2016 Dec; 111():55-65. PubMed ID: 27723556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis and Control of in Vivo Kinetics of Exosomes for the Development of Exosome-based DDS].
    Takahashi Y; Nishikawa M; Takakura Y
    Yakugaku Zasshi; 2016; 136(1):49-53. PubMed ID: 26725667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced Class I Tumor Antigen Presentation via Cytosolic Delivery of Exosomal Cargos by Tumor-Cell-Derived Exosomes Displaying a pH-Sensitive Fusogenic Peptide.
    Morishita M; Takahashi Y; Nishikawa M; Ariizumi R; Takakura Y
    Mol Pharm; 2017 Nov; 14(11):4079-4086. PubMed ID: 28977747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell type-specific and common characteristics of exosomes derived from mouse cell lines: Yield, physicochemical properties, and pharmacokinetics.
    Charoenviriyakul C; Takahashi Y; Morishita M; Matsumoto A; Nishikawa M; Takakura Y
    Eur J Pharm Sci; 2017 Jan; 96():316-322. PubMed ID: 27720897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of HIF-1-active tumor hypoxia using a protein effectively delivered to and specifically stabilized in HIF-1-active tumor cells.
    Kudo T; Ueda M; Kuge Y; Mukai T; Tanaka S; Masutani M; Kiyono Y; Kizaka-Kondoh S; Hiraoka M; Saji H
    J Nucl Med; 2009 Jun; 50(6):942-9. PubMed ID: 19443598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated growth of B16BL6 tumor in mice through efficient uptake of their own exosomes by B16BL6 cells.
    Matsumoto A; Takahashi Y; Nishikawa M; Sano K; Morishita M; Charoenviriyakul C; Saji H; Takakura Y
    Cancer Sci; 2017 Sep; 108(9):1803-1810. PubMed ID: 28667694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and preliminary biological evaluation of (3-iodobenzoyl)norbiotinamide and ((5-iodo-3-pyridinyl)carbonyl)norbiotinamide: two radioiodinated biotin conjugates with improved stability.
    Foulon CF; Alston KL; Zalutsky MR
    Bioconjug Chem; 1997; 8(2):179-86. PubMed ID: 9095358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A tetravalent single-chain antibody-streptavidin fusion protein for pretargeted lymphoma therapy.
    Schultz J; Lin Y; Sanderson J; Zuo Y; Stone D; Mallett R; Wilbert S; Axworthy D
    Cancer Res; 2000 Dec; 60(23):6663-9. PubMed ID: 11118050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Extracellular Vesicle Surface Proteins in the Pharmacokinetics of Extracellular Vesicles.
    Charoenviriyakul C; Takahashi Y; Morishita M; Nishikawa M; Takakura Y
    Mol Pharm; 2018 Mar; 15(3):1073-1080. PubMed ID: 29382201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vivo Tracking of Extracellular Vesicles in Mice Using Fusion Protein Comprising Lactadherin and Gaussia Luciferase.
    Takahashi Y; Nishikawa M; Takakura Y
    Methods Mol Biol; 2017; 1660():245-254. PubMed ID: 28828662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue distribution of avidin and streptavidin injected to mice. Effect of avidin carbohydrate, streptavidin truncation and exogenous biotin.
    Schechter B; Silberman R; Arnon R; Wilchek M
    Eur J Biochem; 1990 Apr; 189(2):327-31. PubMed ID: 2186907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotin reagents for antibody pretargeting. 2. Synthesis and in vitro evaluation of biotin dimers and trimers for cross-linking of streptavidin.
    Wilbur DS; Pathare PM; Hamlin DK; Weerawarna SA
    Bioconjug Chem; 1997; 8(6):819-32. PubMed ID: 9404654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biotin reagents for antibody pretargeting. 3. Synthesis, radioiodination, and evaluation of biotinylated starburst dendrimers.
    Wilbur DS; Pathare PM; Hamlin DK; Buhler KR; Vessella RL
    Bioconjug Chem; 1998; 9(6):813-25. PubMed ID: 9815176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Streptavidin in antibody pretargeting. 3. Comparison of biotin binding and tissue localization of 1,2-cyclohexanedione and succinic anhydride modified recombinant streptavidin.
    Wilbur DS; Hamlin DK; Meyer DL; Mallett RW; Quinn J; Vessella RL; Press OW
    Bioconjug Chem; 2002; 13(3):611-20. PubMed ID: 12009953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretargeted radioimmunotherapy using genetically engineered antibody-streptavidin fusion proteins for treatment of non-hodgkin lymphoma.
    Park SI; Shenoi J; Frayo SM; Hamlin DK; Lin Y; Wilbur DS; Stayton PS; Orgun N; Hylarides M; Buchegger F; Kenoyer AL; Axtman A; Gopal AK; Green DJ; Pagel JM; Press OW
    Clin Cancer Res; 2011 Dec; 17(23):7373-82. PubMed ID: 21976541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of bis-biotin-containing reagents for applications utilizing monoclonal antibody-based pretargeting systems with streptavidin mutants.
    Wilbur DS; Park SI; Chyan MK; Wan F; Hamlin DK; Shenoi J; Lin Y; Wilbur SM; Buchegger F; Pantelias A; Pagel JM; Press OW
    Bioconjug Chem; 2010 Jul; 21(7):1225-38. PubMed ID: 20597486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.